Note: Ingredients listed on restricted chemical lists
EC/CAS
137-58-6
Name of the chemical
Lidocaine (INN)
Concentration
N/A
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
N/A
General Information
Revision date
2016-07-06
Product name
LIDOCAINE OINTMENT
Product Synonyms
Lidocaine ointment
1.2.1 Relevant identified uses
topical anaesthetic
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361, H401, H411
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
2.1 Classification of the substance or mixture
UN GHS
Hazard categories
Category
Hazard statements
Reproductive toxicity 2 H361 Acute aquatic toxicity 2 H401 Chronic aquatic toxicity 2 H411 # Refer to Section 16 'Other Information' H361 Suspected of damaging fertility or the unborn child. H411 Toxic to aquatic life with long lasting effects.
Signal word
Warning
Precautionary statements
P201 Obtain special instructions before use. P273 Avoid release to the environment. P281 Use personal protective equipment as required. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage. P501 : Dispose of contents/ container to an approved incineration plant.
2.3 Other hazards
See Section 11.
